Picture of Ironwood Pharmaceuticals logo

IRWD — Ironwood Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

Ironwood Pharmaceuticals Inc reports results for the quarter ended in September 30 - Earnings Summary

* Ironwood Pharmaceuticals Inc  IRWD.OQ  reported quarterly
adjusted earnings of 2 cents​​ per share for the quarter ended
September 30, lower than the same quarter last year, when the
company reported EPS of 9 cents.  The mean expectation of
six analysts for the quarter was for earnings of 8 cents per
share. Wall Street expected results to range from 1 cents to 18
cents per share.
    * Revenue fell 19.5% to $91.59 million from a year ago;
analysts
expected $91.25 million. 
    * Ironwood Pharmaceuticals Inc's reported EPS for the
quarter was
2 cents​.
    * The company reported quarterly net income of $3.65
million.
    * Ironwood Pharmaceuticals Inc shares had risen by 13.1%
this
quarter and lost 59.3% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 0.1%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Ironwood
Pharmaceuticals Inc is 12.00 
This summary was machine generated from LSEG data November 8 at
05:21 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      0.08           0.02           Missed
 Jun. 30 2024      0.15           0.00           Missed
 Mar. 31 2024      0.19           -0.02          Missed
 Dec. 31 2023      0.21           -0.01          Missed

Recent news on Ironwood Pharmaceuticals

See all news